TUESDAY, Nov. 13, 2018 -- Icosapent ethyl is associated with a reduced risk for ischemic events among patients with elevated triglyceride levels despite taking statins, according to a study published online Nov. 10 in the New England Journal of...
Original Article: AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides